全球药物安全检测市场规模、份额、成长分析（按类型、应用、最终用户）- 产业预测，2024-2031 年

2022年全球药物安全检测市场规模为90.7亿美元，从2023年的97.5亿美元成长到2031年的173.9亿美元，预计在预测期间（2024-2031年）将以复合年增长率成长。

由于对病人安全的日益关注、监管标准的收紧和製药领域的扩大，全球药物安全检测市场正在显着增长。此市场分析提供了对全球药物安全检测市场的主要趋势、驱动因素/挑战和区域差异的见解。推动药物安全检测市场扩张的关键因素是对药物安全性监测的需求不断增加，特别是面对药物复杂性的增加和新疗法的出现。世界各地的监管机构正在执行严格的指导方针，并鼓励製药公司采用强有力的药物安全检测通讯协定，从而促进市场成长。此外，慢性病的流行和药物消费的快速增加强调了药物安全检测的重要性。副作用和用药错误对病人健康、医疗保健支出和法律义务的影响强调了有效药物安全检测系统的必要性。因此，医疗保健提供者和监管机构强调需要强大的药物安全检测机制来快速识别和解决不利事件，从而提高病患安全和整体医疗保健结果。

目录

执行摘要

• 市场概况
• 繁荣与衰落

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模估算
• 市场危机与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管环境
• 波特的分析
• 对未来中断的特殊考虑

全球药物安全检测市场：按类型

• 市场概况
• 内部药物警戒与合约外包药物警戒

全球药物安全检测市场：依应用分类

• 市场概况
• 自愿报告
• 中央监控程序
• 上市后监测
• 危机管理
• 讯号检测与评估
• 效益-风险评估与安全资料库管理

全球药物安全检测市场：依最终使用者分类

• 市场概况
• 製药公司
• 合约研究组织 (CRO) 和其他医疗保健提供者

全球药物安全检测市场规模：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• QuintilesIMS（美国）
• 埃森哲（爱尔兰）
• 高知特（美国）
• IBM公司（美国）
• 甲骨文公司（美国）
• PAREXEL国际公司（美国）
• ArisGlobal（美国）
• ICON plc（爱尔兰）
• IQVIA（美国）
• PRA 健康科学（美国）
• Wipro 有限公司（印度）
• 凯捷公司（法国）
• 塔塔咨询服务有限公司（印度）
• BioClinica, Inc.（美国）
• Sciformix 公司（美国）
• 科文斯公司（美国）
• Bioclinica（美国）
• HCL 技术有限公司（印度）
• Foresight Group International AG（瑞士）
• TAKE 解决方案有限公司（印度）

Global Pharmacovigilance Market size was valued at USD 9.07 billion in 2022 and is poised to grow from USD 9.75 billion in 2023 to USD 17.39 billion by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

The global pharmacovigilance market has witnessed substantial growth due to heightened attention to patient safety, escalating regulatory standards, and the expanding pharmaceutical sector. This market analysis offers insights into key trends, drivers, challenges, and regional variations within the global pharmacovigilance market. A pivotal factor propelling its expansion is the escalating demand for monitoring drug safety, particularly in the face of burgeoning drug complexity and the advent of novel therapeutics. Regulatory bodies worldwide are enforcing rigorous guidelines, compelling pharmaceutical firms to adopt robust pharmacovigilance protocols, thus propelling market growth. Moreover, the surge in chronic disease prevalence and medication consumption underscores the criticality of pharmacovigilance. The ramifications of adverse drug reactions and medication errors on patient well-being, healthcare expenditure, and legal obligations highlight the imperative for effective pharmacovigilance systems. Consequently, healthcare providers and regulatory entities stress the necessity for robust pharmacovigilance mechanisms to promptly identify and address adverse events, thereby augmenting patient safety and overall healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pharmacovigilance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacovigilance Market Segmental Analysis

The global pharmacovigilance market is segmented on the basis of type, application, end-user and region. Based on type, the market can be segmented into In-House Pharmacovigilance and Contract Outsourcing Pharmacovigilance. Based on application, the market is segmented into Spontaneous Reporting, Intensive Monitoring Programs, Post-Marketing Surveillance, Risk Management, Signal Detection and Evaluation, Benefit-Risk Assessment and Safety Database Management. By End - user it can be segmented into Pharmaceutical Companies, Contract Research Organizations (CROs) and Other Healthcare Providers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Pharmacovigilance Market

The upward trend in adverse drug reactions (ADRs) globally propels the pharmacovigilance market forward, spurred by the expanding use of pharmaceuticals which heightens the likelihood of encountering unforeseen adverse events. Pharmacovigilance assumes a pivotal role in monitoring and documenting ADRs, enabling prompt detection, risk assessment, and implementation of necessary interventions to ensure patient safety. The increasing incidence of ADRs underscores the necessity for pharmacovigilance services and solutions, thus propelling the growth of the market.

Restraints in the Global Pharmacovigilance Market

One of the challenges faced by the global pharmacovigilance market stems from the insufficient awareness and infrastructure in developing regions, which struggle to establish and execute robust pharmacovigilance systems. The lack of understanding regarding the importance of pharmacovigilance, coupled with inadequate regulatory structures and resource limitations, obstructs the uptake of efficient pharmacovigilance protocols. Additionally, the dearth of infrastructure, shortage of trained personnel, and inadequate data management systems present further obstacles to the expansion of the pharmacovigilance market in these areas.

Market Trends of the Global Pharmacovigilance Market

In recent years, there has been a notable surge in drug consumption and development, which, when coupled with prolonged use and widespread usage, poses potential risks of adverse effects for patients. Consequently, the increasing demand for medical oversight from regulatory bodies acts as a catalyst for the expansion of the pharmacovigilance market. Furthermore, the pharmaceutical sector has increasingly embraced pharmacovigilance services, driving growth in this sector. For instance, the collaboration between IQVIA and NRx Pharmaceuticals in September 2021 aimed to offer pharmacovigilance services and medical information, ensuring preparedness for potential regulatory actions. These industry trends underscore the growing acknowledgment of the pivotal role pharmacovigilance plays in ensuring drug safety and regulatory adherence.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global PharmaCovigilances Market by Type

• Market Overview
• In-House Pharmacovigilance and Contract Outsourcing Pharmacovigilance

Global PharmaCovigilances Market by Application

• Market Overview
• Spontaneous Reporting
• Intensive Monitoring Programs
• Post-Marketing Surveillance
• Risk Management
• Signal Detection and Evaluation
• Benefit-Risk Assessment and Safety Database Management.

Global PharmaCovigilances Market by End-User

• Market Overview
• Pharmaceutical Companies
• Contract Research Organizations (CROs) and Other Healthcare Providers.

Global PharmaCovigilances Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• QuintilesIMS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accenture (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArisGlobal (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wipro Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capgemini SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tata Consultancy Services Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioClinica, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciformix Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioclinica (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HCL Technologies Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foresight Group International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAKE Solutions Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments